{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T05:12:34Z","timestamp":1783055554416,"version":"3.54.6"},"reference-count":63,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T00:00:00Z","timestamp":1750464000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T00:00:00Z","timestamp":1750464000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Chronic Disease"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Antiretroviral therapy (ART) has significantly reduced morbidity and mortality among people living with HIV (PLWH). However, data on the burden of metabolic syndrome (MetS) in sub-Saharan Africa remains limited, particularly following the implementation of universal test-and-treat strategies and the widespread use of integrase inhibitor-based combinations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>This study aimed to determine the prevalence and associated factors of MetS among adults receiving first-line ART in the Hawassa City Administration, southern Ethiopia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>A cross-sectional study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The study was conducted from January 2023 to May 2024, adapting the World Health Organization (WHO) stepwise approach to collect data. All study-relevant data were collected from participants using a pretested structured questionnaire. MetS was defined according to the 2009 harmonized criteria. A binary logistic regression analysis was conducted to identify predictors of MetS, with adjusted odds ratio (aOR) and 95% confidence intervals (CIs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 450 adults participated in the study, of whom 262 (58.2%) were females. The mean (standard deviation) age of the participants was 41.1(\u00b19.7) years. The prevalence of MetS was 36.4% (95% CI: 32.2\u201341.6), with low high-density lipoprotein (HDL) cholesterol as the most frequent component observed in 368 (81.8%) participants. Age &gt;50 years (aOR: 2.9; 95% CI: 1.4\u20136.2), alcohol use (aOR: 2.7; 95% CI: 1.2\u20136.4), body mass index \u2a7e25 kg\/m\u00b2 (aOR: 3.7; 95% CI: 1.9\u20137.1), triglyceride\/HDL-cholesterol ratio (aOR: 1.5; 95% CI: 1.3\u20131.7), family history of hypertension (aOR: 2.1; 95% CI: 1.1\u20133.8), and high waist-height ratio (aOR: 5.4; 95% CI: 1.8\u201315.9) were significantly associated with MetS. However, dolutegravir-based first-line regimens were not significantly associated with MetS (p=0.482 for DTG initiation, and p=0.34 for switching to DTG).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The noticeable prevalence of MetS among PLWH highlights its potential to increase cardiovascular risks. Therefore, routine screening of PLWH for components of MetS is essential to reduce the health risks associated with metabolic disorders. As most of the identified risk factors are modifiable, implementing lifestyle interventions is also imperative.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/20406223251346289","type":"journal-article","created":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T06:10:07Z","timestamp":1750486207000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Prevalence and determinants of metabolic syndrome among adults living with HIV on first-line antiretroviral treatment in southern Ethiopia: a cross-sectional study"],"prefix":"10.1177","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8426-051X","authenticated-orcid":false,"given":"Agete Tadewos","family":"Hirigo","sequence":"first","affiliation":[{"name":"School of Medical Laboratory Science, College of Medicine and Health Sciences, Hawassa University, PO Box 1560, Hawassa, Southern Ethiopia, Ethiopia"},{"name":"Center for Food Science and Nutrition, Addis Ababa University, Addis Ababa, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Yilma","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, College of Public Health and Medical Sciences, Jimma University, Jimma, Ethiopia"},{"name":"Clinical Trial Unit, Jimma University, Jimma, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayalew","family":"Astatkie","sequence":"additional","affiliation":[{"name":"School of Public Health, College of Medicine and Health Sciences, Hawassa University, Hawassa, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelalem","family":"Debebe","sequence":"additional","affiliation":[{"name":"Center for Food Science and Nutrition, Addis Ababa University, Addis Ababa, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,6,21]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.001180"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.192644"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.21.2709"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.192644"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102255"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-024-20118-3"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.91191"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-018-0927-y"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-023-01034-9"},{"issue":"1","key":"e_1_3_4_11_2","first-page":"2701309","article-title":"The prevalence of metabolic syndrome in Ethiopian population: a systematic review and meta-analysis","volume":"2020","author":"Ambachew S","year":"2020","unstructured":"Ambachew S, Endalamaw A, Worede A, et al. The prevalence of metabolic syndrome in Ethiopian population: a systematic review and meta-analysis. J Obes 2020; 2020(1): 2701309.","journal-title":"J Obes"},{"key":"e_1_3_4_12_2","first-page":"4941","article-title":"Metabolic syndrome among working adults in Eastern Ethiopia","volume":"2020","author":"Motuma A","unstructured":"Motuma A, Gobena T, Teji Roba K, et al. Metabolic syndrome among working adults in Eastern Ethiopia. Diabetes Metab Syndr Obes 2020:4941\u20134951.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1080\/15284336.2017.1311502"},{"key":"e_1_3_4_14_2","first-page":"5019025","article-title":"Determinants of metabolic syndrome and 5-year cardiovascular risk estimates among HIV-positive individuals from an Indian Tertiary Care Hospital","volume":"2020","author":"Mallya SD","year":"2020","unstructured":"Mallya SD, Reddy TS, Kamath A, et al. Determinants of metabolic syndrome and 5-year cardiovascular risk estimates among HIV-positive individuals from an Indian Tertiary Care Hospital. AIDS Res Treat 2020; 2020: 5019025.","journal-title":"AIDS Res Treat"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.2174\/1570162X18666200609115615"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2018.29.90.13328"},{"key":"e_1_3_4_17_2","unstructured":"World Health Organization. Updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV: interim guidelines: supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. World Health Organization 2018. https:\/\/www.who.int\/publications\/i\/item\/WHO-CDS-HIV-18.51"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.3389\/frph.2023.1133556"},{"issue":"6","key":"e_1_3_4_19_2","article-title":"Prevalence of cardiometabolic disease risk factors in people with HIV initiating antiretroviral therapy at a High-Volume HIV Clinic in Kampala, Uganda","volume":"10","author":"Amutuhaire W","year":"2023","unstructured":"Amutuhaire W, Mulindwa F, Castelnuovo B, et al. (eds.). Prevalence of cardiometabolic disease risk factors in people with HIV initiating antiretroviral therapy at a High-Volume HIV Clinic in Kampala, Uganda. Open Forum Infect Dis 2023; 10(6): ofad241.","journal-title":"Open Forum Infect Dis"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-023-08892-8"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.13273"},{"key":"e_1_3_4_22_2","article-title":"Weight gain in incarcerated individuals living with HIV after switching to integrase strand inhibitor-based therapy","volume":"20","author":"Goldberg RN","year":"2021","unstructured":"Goldberg RN, Kania AT, Michienzi SM, et al. Weight gain in incarcerated individuals living with HIV after switching to integrase strand inhibitor-based therapy. J Intl Assoc Prov AIDS Care 2021; 20: 2325958221996860.","journal-title":"J Intl Assoc Prov AIDS Care"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz999"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2023.2242250"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1177\/09564624221129410"},{"issue":"6","key":"e_1_3_4_26_2","first-page":"7","article-title":"Prevalence of hyperglycemia in HIV patients on dolutegravir ART regimen receiving care at Jinja Regional Referral Hospital. A cross-sectional study","volume":"1","author":"Mugoya A","year":"2024","unstructured":"Mugoya A, Ogwal IA. Prevalence of hyperglycemia in HIV patients on dolutegravir ART regimen receiving care at Jinja Regional Referral Hospital. A cross-sectional study. Diabetes Hypertens Cancer Res Afr 2024; 1(6): 7.","journal-title":"Diabetes Hypertens Cancer Res Afr"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-014-0266-2"},{"issue":"1","key":"e_1_3_4_28_2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4103\/ijph.ijph_1060_22","article-title":"Metabolic syndrome in people living with antiretroviral therapy: a cross-sectional investigation from Pune, India","volume":"67","author":"Shidhaye P","year":"2023","unstructured":"Shidhaye P, Ghate M, Gurav S, et al. Metabolic syndrome in people living with antiretroviral therapy: a cross-sectional investigation from Pune, India. Indian J Public Health 2023; 67(1): 84\u201391.","journal-title":"Indian J Public Health"},{"key":"e_1_3_4_29_2","volume-title":"The WHO STEPwise Approach to Chronic Disease Risk Factor Surveillance (STEPS)","author":"World Health Organization","year":"2011","unstructured":"World Health Organization. The WHO STEPwise Approach to Chronic Disease Risk Factor Surveillance (STEPS). Geneva: World Health Organization, 2011."},{"key":"e_1_3_4_30_2","volume-title":"STEPwise approach to surveillance (STEPS)","author":"World Health Organization","year":"2008","unstructured":"World Health Organization. STEPwise approach to surveillance (STEPS). Geneva, Switzerland, 2008."},{"key":"e_1_3_4_31_2","unstructured":"OMRON: HBF-514 full body sensor body composition monitor and scalfull body sensor body composition monitor and scale manual. Omron Healthcare Co. Ltd. https:\/\/omronhealthcare.com\/storage\/pdfs\/1665708-0f_hbf-514c-z_e_m_web_alt_text_acc.pdf (2024 accessed 5 July 2024)."},{"key":"e_1_3_4_32_2","unstructured":"World Health Organization. A healthy lifestyle\u2014WHO recommendations https:\/\/wwwwhoint\/europe\/news-room\/fact-sheets\/item\/a-healthy-lifestyle\u2014who-recommendations (2020 cited 22 February 2022 accessed 12 May 2024)."},{"key":"e_1_3_4_33_2","volume-title":"Waist circumference and waist-hip ratio: report of a WHO expert consultation","author":"World Health Organization","year":"2011","unstructured":"World Health Organization. Waist circumference and waist-hip ratio: report of a WHO expert consultation. Geneva, 8\u201311 December 2008. 2011."},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.4103\/ijcm.IJCM_196_16"},{"issue":"3","key":"e_1_3_4_35_2","first-page":"155","article-title":"Effect of substance use on academic achievement of health officer and medical students of Jimma University, Southwest Ethiopia","volume":"19","author":"Meressa K","year":"2009","unstructured":"Meressa K, Mossie A, Gelaw Y. Effect of substance use on academic achievement of health officer and medical students of Jimma University, Southwest Ethiopia. Ethiop J Health Sci 2009; 19(3): 155\u2013163.","journal-title":"Ethiop J Health Sci"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1249\/01.MSS.0000078924.61453.FB"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2014.04.008"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150970"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0289155"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-018-0312-y"},{"key":"e_1_3_4_41_2","volume-title":"Metabolic syndrome among working adults in Eastern Ethiopia","author":"Abdi AM","year":"2022","unstructured":"Abdi AM (ed.). Metabolic syndrome among working adults in Eastern Ethiopia. 33rd EPHA Annual Conference, Addis Ababa, Ethiopia, 2022."},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-99913-6"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0257306"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnesp.2023.01.034"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-018-3444-0"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2015.0213"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.4314\/ahs.v22i1.50"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2023.2295435"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0247004"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0250328"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2017.03.046"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S453699"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000025236"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI158451"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1089\/met.2014.0146"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2023.117737"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S287281"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-015-1927-7"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.4330\/wjc.v6.i5.245"},{"key":"e_1_3_4_60_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.124.22703"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.758230"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad359"},{"key":"e_1_3_4_63_2","article-title":"Impact of dolutegravir-based regimen on metabolic syndrome and its components in adults with HIV in care at Hospital Roosevelt in Guatemala City","volume":"10","author":"Farf\u00e1n AJM","year":"1586","unstructured":"Farf\u00e1n AJM, Marroquin H, Ortiz D, et al. 1586. Impact of dolutegravir-based regimen on metabolic syndrome and its components in adults with HIV in care at Hospital Roosevelt in Guatemala City. Open Forum Infect Dis 2023; 10(Suppl 2): ofad500.1421.","journal-title":"Open Forum Infect Dis"},{"key":"e_1_3_4_64_2","doi-asserted-by":"publisher","DOI":"10.1177\/23259582241303305"}],"container-title":["Therapeutic Advances in Chronic Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20406223251346289","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/20406223251346289","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20406223251346289","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:20:11Z","timestamp":1777591211000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/20406223251346289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,21]]},"references-count":63,"alternative-id":["10.1177\/20406223251346289"],"URL":"https:\/\/doi.org\/10.1177\/20406223251346289","relation":{},"ISSN":["2040-6223","2040-6231"],"issn-type":[{"value":"2040-6223","type":"print"},{"value":"2040-6231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,21]]},"article-number":"20406223251346289"}}